Brain, Vol. 124, No. 9, 1813-1820,
September 2001
© 2001 Oxford University Press
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis
1 Centre for Functional Magnetic Resonance Imaging of the Brain and 2 Department of Clinical Neurology, University of Oxford, UK
Correspondence to:
Professor P. M. Matthews, Centre for Functional Magnetic Resonance Imaging of the Brain, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK E-mail: paul{at}fmrib.ox.ac.uk
Axonal damage is found in both acute and chronic lesions of multiple sclerosis. Direct axon counting in post-mortem tissue has suggested that smaller axons might have a greater susceptibility to damage, but methodological limitations have precluded unequivocal interpretation. However, as neuronal and axonal sizes are linked and neuronal changes would be expected with retrograde or transsynaptic degeneration following axon injury, we hypothesized that an alternative strategy for studying this phenomenon would be to define multiple sclerosis-associated changes in neurones. To test this hypothesis, we measured both axonal loss and neuronal size changes in the anterior optic pathway [including the optic nerve (ON), optic tract (OT) and lateral geniculate nucleus] of the brains of eight patients who died with multiple sclerosis and in eight control brains. The ONs and OTs in brains from the multiple sclerosis patients showed a trend to smaller mean cross-sectional areas (ON, multiple sclerosis = 6.84 mm2, controls = 9.25 mm2; and OT, multiple sclerosis = 6.45 mm2, controls = 7.94 mm2, P = 0.08) and had reduced axonal densities (ON, multiple sclerosis = 1.1 x 105/mm2, controls = 1.7 x 105/mm2; and OT, multiple sclerosis = 1.4 x 105/mm2, controls = 1.8 x 105/mm2, P = 0.006). Estimated total axonal counts were reduced by 32 (OT)–45% (ON) in the patients relative to controls (ON, multiple sclerosis = 8.1 x 105 axons, controls = 14.8 x105, P = 0.05; and OT, multiple sclerosis = 9.1 x 105, controls = 13.3 x 105, P = 0.02). The size distributions of the magnocellular cells in the lateral geniculate nucleus were similar for the two groups, but in multiple sclerosis brains the parvocellular cells were significantly smaller (mean sizes: multiple sclerosis = 226 µm2, controls = 230 µm2, P < 0.001) and had a larger variation in size, suggesting a greater proportion of atrophic neurones. Axon loss in the optic nerves of multiple sclerosis patients correlated strongly with measures of increased dispersion of cell sizes in the parvocellular layer (r = 0.8, P < 0.04). These data demonstrate that both atrophy and decreased density contribute to the substantial axonal loss in the anterior visual pathway of these patients. This appears related to a relatively selective atrophy of the smaller neurones of the parvocellular layer in the lateral geniculate nucleus, supporting the hypothesis that smaller axons may be preferentially susceptible to injury in multiple sclerosis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. M. Burkholder, B. Osborne, M. J. Loguidice, E. Bisker, T. C. Frohman, A. Conger, J. N. Ratchford, C. Warner, C. E. Markowitz, D. A. Jacobs, et al. Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis Arch Neurol, November 1, 2009; 66(11): 1366 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.P. Sampat, A.M. Berger, B.C. Healy, P. Hildenbrand, J. Vass, D.S. Meier, T. Chitnis, H.L. Weiner, R. Bakshi, and C.R.G. Guttmann Regional White Matter Atrophy-Based Classification of Multiple Sclerosis in Cross-Sectional and Longitudinal Data AJNR Am. J. Neuroradiol., October 1, 2009; 30(9): 1731 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Furby, T Hayton, D Altmann, R Brenner, J Chataway, K. Smith, D. Miller, and R Kapoor Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis Multiple Sclerosis, June 1, 2009; 15(6): 687 - 694. [Abstract] [PDF]
|
|
|
|
|
|
J. Sepulcre, J. Goni, J. C. Masdeu, B. Bejarano, N. Velez de Mendizabal, J. B. Toledo, and P. Villoslada Contribution of White Matter Lesions to Gray Matter Atrophy in Multiple Sclerosis: Evidence From Voxel-Based Analysis of T1 Lesions in the Visual Pathway Arch Neurol, February 1, 2009; 66(2): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R G Henry, M Shieh, D T Okuda, A Evangelista, M L Gorno-Tempini, and D Pelletier Regional grey matter atrophy in clinically isolated syndromes at presentation J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1236 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Zaveri, A. Conger, A. Salter, T. C. Frohman, S. L. Galetta, C. E. Markowitz, D. A. Jacobs, G. R. Cutter, G.-S. Ying, M. G. Maguire, et al. Retinal Imaging by Laser Polarimetry and Optical Coherence Tomography Evidence of Axonal Degeneration in Multiple Sclerosis Arch Neurol, July 1, 2008; 65(7): 924 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Anderson, D. W. Hampton, R. Patani, G. Pryce, R. A. Crowther, R. Reynolds, R. J. M. Franklin, G. Giovannoni, D. A. S. Compston, D. Baker, et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis Brain, July 1, 2008; 131(7): 1736 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Frohman, F. Costello, O. Stuve, P. Calabresi, D. H. Miller, S. J. Hickman, R. Sergott, A. Conger, A. Salter, K. H. Krumwiede, et al. Modeling Axonal Degeneration Within the Anterior Visual System: Implications for Demonstrating Neuroprotection in Multiple Sclerosis Arch Neurol, January 1, 2008; 65(1): 26 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Cheng, M. Laron, J. S. Schiffman, R. A. Tang, and L. J. Frishman The Relationship between Visual Field and Retinal Nerve Fiber Layer Measurements in Patients with Multiple Sclerosis Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5798 - 5805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Klistorner, S. Graham, C. Fraser, R. Garrick, T. Nguyen, M. Paine, J. O'Day, J. Grigg, H. Arvind, and F. A. Billson Electrophysiological Evidence for Heterogeneity of Lesions in Optic Neuritis Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4549 - 4556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Audoin, G. Davies, W. Rashid, L. Fisniku, A.J. Thompson, and D.H. Miller Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis Multiple Sclerosis, May 1, 2007; 13(4): 483 - 489. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Sepulcre, M. Murie-Fernandez, A. Salinas-Alaman, A. Garcia-Layana, B. Bejarano, and P. Villoslada Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS Neurology, May 1, 2007; 68(18): 1488 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.M. Saindane, M. Law, Y. Ge, G. Johnson, J.S. Babb, and R.I. Grossman Correlation of Diffusion Tensor and Dynamic Perfusion MR Imaging Metrics in Normal-Appearing Corpus Callosum: Support for Primary Hypoperfusion in Multiple Sclerosis AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 767 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Patrikios, C. Stadelmann, A. Kutzelnigg, H. Rauschka, M. Schmidbauer, H. Laursen, P. S. Sorensen, W. Bruck, C. Lucchinetti, and H. Lassmann Remyelination is extensive in a subset of multiple sclerosis patients Brain, December 1, 2006; 129(12): 3165 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J H Simon Brain atrophy in multiple sclerosis: what we know and would like to know Multiple Sclerosis, November 1, 2006; 12(6): 679 - 687. [Abstract] [PDF]
|
|
|
|
|
|
G. C. DeLuca, K. Williams, N. Evangelou, G. C. Ebers, and M. M. Esiri The contribution of demyelination to axonal loss in multiple sclerosis Brain, June 1, 2006; 129(6): 1507 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Audoin, K. T. M. Fernando, J. K. Swanton, A. J. Thompson, G. T. Plant, and D. H. Miller Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis Brain, April 1, 2006; 129(4): 1031 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Gilmore, G. C. DeLuca, L. Bo, T. Owens, J. Lowe, M. M. Esiri, and N. Evangelou Spinal Cord Atrophy in Multiple Sclerosis Caused by White Matter Volume Loss Arch Neurol, December 1, 2005; 62(12): 1859 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rovaris, A. Gass, R. Bammer, S. J. Hickman, O. Ciccarelli, D. H. Miller, and M. Filippi Diffusion MRI in multiple sclerosis Neurology, November 22, 2005; 65(10): 1526 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Caramanos, S. Narayanan, and D. L. Arnold 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review Brain, November 1, 2005; 128(11): 2483 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M A Rocca, S J Hickman, L Bo, F Agosta, D H Miller, G Comi, and M Filippi Imaging the optic nerve in multiple sclerosis Multiple Sclerosis, October 1, 2005; 11(5): 537 - 541. [Abstract] [PDF]
|
|
|
|
|
|
P. G. Bannerman, A. Hahn, S. Ramirez, M. Morley, C. Bonnemann, S. Yu, G.-X. Zhang, A. Rostami, and D. Pleasure Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice Brain, August 1, 2005; 128(8): 1877 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sisto, M. Trojano, M. Vetrugno, T. Trabucco, G. Iliceto, and C. Sborgia Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1264 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Intino, M. Paradisi, M. Fernandez, A. Giuliani, L. Aloe, L. Giardino, and L. Calza Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats PNAS, February 22, 2005; 102(8): 3070 - 3075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S K Ludwin Pathologic Classification Systems in MS: What is their Significance? Multiple Sclerosis, February 1, 2005; 11(1): 106 - 107. [PDF]
|
|
|
|
|
|
D. A. Bechtold, X. Yue, R. M. Evans, M. Davies, N. A. Gregson, and K. J. Smith Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide Brain, January 1, 2005; 128(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Amato, M. L. Bartolozzi, V. Zipoli, E. Portaccio, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and N. De Stefano Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment Neurology, July 13, 2004; 63(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wegner and P.M. Matthews A new view of the cortex, new insights into multiple sclerosis Brain, August 1, 2003; 126(8): 1719 - 1721. [Full Text] [PDF]
|
|
|
|
|
|
H Lassmann Axonal injury in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 695 - 697. [Full Text] [PDF]
|
|
|
|
|
|
N. De Stefano, P. M. Matthews, M. Filippi, F. Agosta, M. De Luca, M. L. Bartolozzi, L. Guidi, A. Ghezzi, E. Montanari, A. Cifelli, et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability Neurology, April 8, 2003; 60(7): 1157 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Medana and M. M. Esiri Axonal damage: a key predictor of outcome in human CNS diseases Brain, March 1, 2003; 126(3): 515 - 530. [Abstract] [Full Text] [PDF]
|
|